Analysts’ Top Healthcare Picks: Acadia Healthcare (ACHC), Kiniksa Pharmaceuticals (KNSA)
TipRanks (Thu, 26-Feb 8:40 AM ET)
Cantor Fitzgerald Keeps Their Hold Rating on Acadia Healthcare (ACHC)
TipRanks (Thu, 26-Feb 8:35 AM ET)
TipRanks (Wed, 25-Feb 8:35 PM ET)
Seeking Alpha News (Wed, 25-Feb 3:08 PM ET)
Benzinga (Wed, 25-Feb 10:16 AM ET)
TipRanks (Wed, 25-Feb 9:50 AM ET)
Volume Growth Drives Acadia's Record Revenue in Q4 2025 as Leadership Shifts with New CEO
Market Chameleon (Wed, 25-Feb 2:54 AM ET)
Acadia Healthcare beats top-line and bottom-line estimates; introduces FY26 outlook
Seeking Alpha News (Wed, 25-Feb 7:18 AM ET)
Acadia Healthcare Announces Fourth Quarter and 2025 Results
Business Wire (Wed, 25-Feb 7:00 AM ET)
Here are the major earnings before the open Wednesday
Seeking Alpha News (Tue, 24-Feb 6:00 PM ET)
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Acadia Healthcare Company trades on the NASDAQ stock market under the symbol ACHC.
As of February 26, 2026, ACHC stock price climbed to $22.29 with 5,309,662 million shares trading.
ACHC has a beta of 0.90, meaning it tends to be less sensitive to market movements. ACHC has a correlation of 0.05 to the broad based SPY ETF.
ACHC has a market cap of $2.02 billion. This is considered a Mid Cap stock.
Last quarter Acadia Healthcare Company reported $821 million in Revenue and $.07 earnings per share. This beat revenue expectation by $22 million and exceeded earnings estimates by $.03.
In the last 3 years, ACHC traded as high as $87.77 and as low as $11.43.
The top ETF exchange traded funds that ACHC belongs to (by Net Assets): IJR, VTI, FXH, VB, IJS.
ACHC has underperformed the market in the last year with a return of -47.4%, while SPY returned +17.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ACHC shares. However, ACHC has outperformed the market in the last 3 month and 2 week periods, returning +34.5% and +43.5%, while SPY returned +2.4% and -0.4%, respectively. This indicates ACHC has been having a stronger performance recently.
ACHC support price is $19.98 and resistance is $21.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHC shares will trade within this expected range on the day.